Skip to main content
. 2022 Jul 7;5(7):e2220543. doi: 10.1001/jamanetworkopen.2022.20543

Table 3. Association of Telemedicine Visit Success With Changes in Systemic Cancer Treatment.

Change in therapy Visits, No. (%) OR for telemedicine (95% CI) Visits, No. (%) OR for successful telemedicine visit (95% CI)
In person (n = 658) Telemedicine (n = 1294) Successful telemedicine (n = 717) Unsuccessful telemedicine (n = 527)
Delay in therapy 44 (6.69) 95 (7.34) 0.97 (0.66-1.42) 51 (7.11) 39 (7.40) 1.06 (0.68-1.65)
Dose increase 1 (0.15) 1 (0.08) 0.45 (0.03-7.19) 1 (0.14) 0 NA
Dose reduction 12 (1.82) 29 (2.24) 1.08 (0.54-2.15) 12 (1.67) 14 (2.66) 0.69 (0.32-1.52)
Hospice 14 (2.13) 20 (1.55) 0.64 (0.32-1.28) 15 (2.09) 4 (0.76) 3.04 (1.00-9.24)
Maintenance 311 (47.26) 694 (53.63) 1 [Reference] 367 (51.19) 297 (56.36) 1 [Reference]
Start of therapy 129 (19.60) 141 (10.9) 0.49 (0.37-0.64) 96 (13.39) 41 (7.78) 1.90 (1.28-2.82)
Surveillance 117 (17.78) 247 (19.09) 0.95 (0.73-1.22) 129 (17.99) 112 (21.25) 0.93 (0.69-1.25)
Switch in therapy 30 (4.56) 67 (5.18) 1.00 (0.64-1.57) 46 (6.42) 20 (3.80) 1.86 (1.08-3.22)

Abbreviation: OR, odds ratio.